RU2013141237A - Способы неинвазивного пренатального установления плоидности - Google Patents
Способы неинвазивного пренатального установления плоидности Download PDFInfo
- Publication number
- RU2013141237A RU2013141237A RU2013141237/15A RU2013141237A RU2013141237A RU 2013141237 A RU2013141237 A RU 2013141237A RU 2013141237/15 A RU2013141237/15 A RU 2013141237/15A RU 2013141237 A RU2013141237 A RU 2013141237A RU 2013141237 A RU2013141237 A RU 2013141237A
- Authority
- RU
- Russia
- Prior art keywords
- dna
- chromosome
- sample
- polymorphic loci
- ploidy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 38
- 238000009434 installation Methods 0.000 title 1
- 210000000349 chromosome Anatomy 0.000 claims abstract 51
- 239000000523 sample Substances 0.000 claims abstract 46
- 238000009396 hybridization Methods 0.000 claims abstract 16
- 230000001605 fetal effect Effects 0.000 claims abstract 15
- 210000003754 fetus Anatomy 0.000 claims abstract 14
- 108700028369 Alleles Proteins 0.000 claims abstract 12
- 230000008774 maternal effect Effects 0.000 claims abstract 10
- 238000005259 measurement Methods 0.000 claims abstract 6
- 108020004414 DNA Proteins 0.000 claims 45
- 239000000203 mixture Substances 0.000 claims 5
- 230000003321 amplification Effects 0.000 claims 4
- 208000036878 aneuploidy Diseases 0.000 claims 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims 4
- 238000003752 polymerase chain reaction Methods 0.000 claims 4
- 230000004544 DNA amplification Effects 0.000 claims 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 2
- 230000003322 aneuploid effect Effects 0.000 claims 2
- 231100001075 aneuploidy Toxicity 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 108091093088 Amplicon Proteins 0.000 claims 1
- 102000053602 DNA Human genes 0.000 claims 1
- 238000001712 DNA sequencing Methods 0.000 claims 1
- 238000007476 Maximum Likelihood Methods 0.000 claims 1
- 206010000210 abortion Diseases 0.000 claims 1
- 231100000176 abortion Toxicity 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 238000004364 calculation method Methods 0.000 claims 1
- 230000007012 clinical effect Effects 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 102000054766 genetic haplotypes Human genes 0.000 claims 1
- 238000007854 ligation-mediated PCR Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000012163 sequencing technique Methods 0.000 claims 1
- 238000007619 statistical method Methods 0.000 claims 1
- 230000009897 systematic effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6862—Ligase chain reaction [LCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N7/00—Computing arrangements based on specific mathematical models
- G06N7/01—Probabilistic graphical models, e.g. probabilistic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/179—Modifications characterised by incorporating arbitrary or random nucleotide sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/113—Time
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/143—Concentration of primer or probe
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/149—Sequential reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/159—Reduction of complexity, e.g. amplification of subsets, removing duplicated genomic regions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2545/00—Reactions characterised by their quantitative nature
- C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
- C12Q2545/114—Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Abstract
1. Способ определения статуса плоидности хромосомы или сегмента хромосомы у вынашиваемого плода, предусматривающий:измерение ДНК в образце, который содержит материнскую ДНК от матери плода и плодную ДНК от плода, во множестве полиморфных локусов в хромосоме или сегменте хромосомы;вычисление на компьютере числа аллелей во множестве полиморфных локусов по измерениям ДНК, выполненным в образце;создание на компьютере множества гипотез плоидности, каждая из которых касается различного возможного состояния плоидности хромосомы или сегмента хромосомы;построение на компьютере модели совместного распределения для ожидаемого числа аллелей во множестве полиморфных локусов в хромосоме или сегменте хромосомы для каждой гипотезы плоидности;определение на компьютере относительной вероятности каждой из гипотез плоидности с использованием модели совместного распределения и числа аллелей, измеренных в образце; иустановление состояния плоидности плода путем отбора состояния плоидности, соответствующего гипотезе с наибольшей вероятностью.2. Способ по п.1, в котором ДНК в образце происходит из материнской плазмы.3. Способ по п.1, в котором способ дополнительно предусматривает предпочтительное приумножение ДНК в образце во множестве полиморфных локусов до этапа измерения.4. Способ по п.3, в котором предпочтительное приумножение ДНК в образце во множестве полиморфных локусов предусматривает:получение множества предварительно циркуляризованных зондов, где каждый зонд нацелен на один из полиморфных локусов, где 3′- и 5′-концы каждого зонда конструируют для гибридизации с областью ДНК, которая отделена от полиморфног
Claims (30)
1. Способ определения статуса плоидности хромосомы или сегмента хромосомы у вынашиваемого плода, предусматривающий:
измерение ДНК в образце, который содержит материнскую ДНК от матери плода и плодную ДНК от плода, во множестве полиморфных локусов в хромосоме или сегменте хромосомы;
вычисление на компьютере числа аллелей во множестве полиморфных локусов по измерениям ДНК, выполненным в образце;
создание на компьютере множества гипотез плоидности, каждая из которых касается различного возможного состояния плоидности хромосомы или сегмента хромосомы;
построение на компьютере модели совместного распределения для ожидаемого числа аллелей во множестве полиморфных локусов в хромосоме или сегменте хромосомы для каждой гипотезы плоидности;
определение на компьютере относительной вероятности каждой из гипотез плоидности с использованием модели совместного распределения и числа аллелей, измеренных в образце; и
установление состояния плоидности плода путем отбора состояния плоидности, соответствующего гипотезе с наибольшей вероятностью.
2. Способ по п.1, в котором ДНК в образце происходит из материнской плазмы.
3. Способ по п.1, в котором способ дополнительно предусматривает предпочтительное приумножение ДНК в образце во множестве полиморфных локусов до этапа измерения.
4. Способ по п.3, в котором предпочтительное приумножение ДНК в образце во множестве полиморфных локусов предусматривает:
получение множества предварительно циркуляризованных зондов, где каждый зонд нацелен на один из полиморфных локусов, где 3′- и 5′-концы каждого зонда конструируют для гибридизации с областью ДНК, которая отделена от полиморфного сайта локуса небольшим количеством оснований, и где небольшое количество составляет 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21-25, 26-30, 31-60 или их комбинацию;
гибридизацию предварительно циркуляризованных зондов с ДНК из образца;
заполнение гэпа между концами гибридизированных зондов с использованием ДНК-полимеразы;
циркуляризацию предварительно циркуляризованного зонда и амплификацию циркуляризованного зонда.
5. Способ по п.3, в котором предпочтительное приумножение ДНК во множестве полиморфных локусов предусматривает:
получение множества опосредованных лигированием зондов ПЦР, где каждый зонд ПЦР нацелен на один из полиморфных локусов, где соответствующие расположенные выше и ниже зонды ПЦР конструируют для гибридизации с областью ДНК на одной цепи ДНК, которая отделена от полиморфного сайта локуса небольшим количеством оснований, и где небольшое количество составляет 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21-25, 26-30, 31-60 или их комбинацию;
гибридизацию зондов опосредованной лигированием ПЦР с ДНК из образца;
заполнение гэпа между концами зонда опосредованной лигированием ПЦР с использованием ДНК-полимеразы;
лигирование зондов опосредованной лигированием ПЦР и
амплификацию дотированных зондов опосредованной лигированием ПЦР.
6. Способ по п.3, в котором предпочтительное приумножение ДНК во множестве полиморфных локусов предусматривает:
получение множества зондов гибридного захвата, которые нацелены на полиморфные локусы;
гибридизацию зондов гибридного захвата с ДНК в образце и
физическое удаление некоторой или всей негибридизированной ДНК из образца ДНК.
7. Способ по п.3, в котором предпочтительное приумножение ДНК во множестве полиморфных локусов предусматривает:
получение множества внутренних прямых праймеров, где каждый праймер нацелен на один из полиморфных локусов, где 3′-конец каждого из внутренних прямых праймеров конструируют для гибридизации с областью ДНК, расположенной выше от полиморфного сайта локуса и отделенной от полиморфного сайта небольшим количеством оснований, и где небольшое количество выбрано из группы, состоящей из 1, 2, 3, 4, 5, 6-10, 11-15, 16-20, 21-25, 26-30 и 31-60 пар оснований;
необязательно получение множества внутренних обратных праймеров, где каждый праймер нацелен на один из полиморфных локусов, где 3′-конец каждого из внутренних обратных праймеров конструируют для гибридизации с областью ДНК, расположенной выше от полиморфного сайта локуса и отделенной от полиморфного сайта небольшим количеством оснований, и где небольшое количество выбрано из группы, состоящей из 1, 2, 3, 4, 5, 6-10, 11-15, 16-20, 21-25, 26-30 и 31-60 пар оснований;
гибридизацию внутренних праймеров с ДНК и
амплификацию ДНК с использованием полимеразной цепной реакции для образования ампликонов.
8. Способ по п.7, дополнительно предусматривающий:
получение множества внешних прямых праймеров, каждый из которых нацелен на один из полиморфных локусов, где каждый из внешних прямых праймеров конструируют для гибридизации с областью ДНК, расположенной выше от соответствующего внутреннего прямого праймера;
необязательно получение множества внешних обратных праймеров, каждый из которых нацелен на один из полиморфных локусов, где каждый из внешних обратных праймеров конструируют для гибридизации с областью ДНК, расположенной непосредственно после соответствующего внутреннего обратного праймера;
гибридизацию первых праймеров с ДНК и
амплификацию ДНК с использованием полимеразной цепной реакции.
9. Способ по п.7, дополнительно предусматривающий:
получение множества внешних обратных праймеров, каждый из которых нацелен на один из полиморфных локусов, где каждый из внешних обратных праймеров конструируют для гибридизации с областью ДНК, расположенной непосредственно после соответствующего внутреннего обратного праймера;
необязательно получение множества внешних прямых праймеров, каждый из которых нацелен на один из полиморфных локусов, где каждый из внешних прямых праймеров конструируют для гибридизации с областью ДНК, расположенной выше от соответствующего внутреннего прямого праймера;
гибридизацию первых праймеров с ДНК и
амплификацию ДНК с использованием полимеразной цепной реакции.
10. Способ по п.7, дополнительно предусматривающий:
добавление универсальных адаптеров к ДНК в образце и
амплификацию ДНК в образце с использованием полимеразной цепной реакции.
11. Способ по п.7, при котором амплификацию ДНК осуществляют в одном или множестве отдельных объемов реакционной смеси, где каждый отдельный объем реакционной смеси содержит более 500 различных пар прямых и обратных праймеров.
12. Способ по п.7, дополнительно предусматривающий разделение первого образца на множество частей, и где ДНК в каждой части предпочтительно приумножают в подмножестве множества полиморфных локусов.
13. Способ по п.7, в котором внутренние праймеры выбирают путем идентификации пар праймеров, способных образовывать нежелательные дуплексы праймеров, и удаления из множества праймеров по меньшей мере одной пары праймеров, идентифицированной как способной образовывать нежелательные дуплексы праймеров.
14. Способ по п.1, дополнительно предусматривающий получение генотипических данных во множестве полиморфных локусов от одного или обоих родителей плода.
15. Способ по п.14, в котором построение модели совместного распределения для ожидаемых вероятностей числа аллелей множества полиморфных локусов в хромосоме или сегменте хромосомы осуществляют с использованием полученных генетических данных от одного или обоих родителей.
16. Способ по п.14, в котором образец выделяют из материнской плазмы, и в котором получение генотипических данных от матери осуществляют путем оценивания материнских генотипических данных по измерениям ДНК, выполненным в образце.
17. Способ по п.3, в котором предпочтительное приумножение дает среднюю степень систематической ошибки подсчета аллелей между образцом после предпочтительного приумножения и образцом перед предпочтительным приумножением с фактором не более чем 1,2.
18. Способ по п.1, в котором множеством полиморфных локусов являются однонуклеотидные полиморфизмы.
19. Способ по п.1, в котором этап измерения ДНК в образце осуществляют путем секвенирования.
20. Способ по п.1, в котором измерения ДНК в образце во множестве полиморфных локусов используют для определения того, унаследовал или не унаследовал плод один или несколько связанных с заболеванием гаплотипов.
21. Способ по п.1, в котором этап построения модели совместного распределения для вероятностей числа аллелей осуществляют с использованием данных о вероятности хромосом, обменивающихся в различных положениях в хромосоме, для моделирования зависимости между полиморфными аллелями в хромосоме.
22. Способ по п.1, в котором как этап построения модели совместного распределения для числа аллелей, так и этап определения относительной вероятности каждой гипотезы выполняют с использованием способа, для которого не требуется применение эталонной хромосомы.
23. Способ по п.1, в котором на этапе определения относительной вероятности каждой гипотезы применяют оцениваемую фракцию плодной ДНК в образце.
24. Способ по п.1, в котором этап установления состояния плоидности плода дополнительно предусматривает:
объединение относительных вероятностей каждой из гипотез плоидности, определенных с использованием модели совместного распределения и вероятностей числа аллелей, с относительными вероятностями каждой из гипотез плоидности, которые рассчитывают с использованием одной или нескольких статистических методик, выбранных из группы, состоящей из анализа подсчета считываний, сравнения степеней гетерозиготности, статистики, которая доступна только при использовании родительской генетической информации, вероятности нормализованных сигналов генотипа для определенных родительских контекстов, статистики, которая рассчитывается с использованием оцениваемой плодной фракции образца, и их комбинаций.
25. Способ по п.1, в котором оценку достоверности рассчитывают для установленного состояния плоидности.
26. Способ по п.25, в котором достоверность превышает 99% для хромосомы 13, хромосомы 18 и хромосомы 21.
27. Способ по п.1, дополнительно предусматривающий:
осуществление клинического действия на основе установленного состояния плоидности плода, где клиническое действие выбирается из прерывания беременности или сохранения беременности.
28. Отчет, показывающий определенный статус плоидности хромосомы или сегмента хромосомы у вынашиваемого плода, сгенерированный с использованием способа по п.1.
29. Набор для определения статуса плоидности целевой хромосомы или сегмента хромосомы у вынашиваемого плода, разработанный для использования со способом по п.7, содержащий:
множество внутренних прямых праймеров и необязательно множество внутренних обратных праймеров, каждый из которых конструируют для гибридизации с областью ДНК, расположенной непосредственно выше и/или ниже одного из полиморфных сайтов в целевой хромосоме или сегменте хромосомы, где область гибридизации отделена от полиморфного сайта небольшим количеством оснований, и где небольшое количество выбрано из группы, состоящей из 1, 2, 3, 4, 5, 6-10, 11-15, 16-20, 21-25, 26-30, 31-60 и их комбинаций.
30. Способ определения наличия или отсутствия анеуплоидии плода, предусматривающий:
(a) выполнение массивно-параллельного секвенирования ДНК фрагментов ДНК, произвольно выбранных из смеси плодной и материнской геномной ДНК, для определения последовательности фрагментов ДНК;
(b) идентификацию хромосом или сегментов хромосом, которым принадлежат последовательности, полученные на этапе (a);
(c) использование данных этапа (b) для определения количества по меньшей мере одной первой хромосомы или сегмента хромосомы в смеси материнской и плодной геномной ДНК, при котором предполагается, что по меньшей мере одна первая хромосома или сегмент хромосомы являются эуплоидными у плода;
(d) использование данных этапа (b) для определения количества второй хромосомы или сегмента хромосомы в смеси материнской и плодной геномной ДНК, при котором ожидается, что вторая хромосома или сегмент хромосомы являются анеуплоидными у плода;
(e) вычисление фракции плодной ДНК в смеси плодной и материнской ДНК;
(f) вычисление ожидаемого распределения количества второй хромосомы или сегмента хромосомы для случая, при котором вторая хромосома или сегмент хромосомы являются эуплоидными, с использованием количества, определенного на этапе (c);
(g) вычисление ожидаемого распределения количества второй хромосомы или сегмента хромосомы для случая, при котором вторая хромосома или сегмент хромосомы являются анеуплоидными, с использованием количества, определенного на этапе (c), и рассчитанной фракции плодной ДНК в смеси плодной и материнской ДНК на этапе (e) и
(h) использование максимального правдоподобия или максимального апостериорного подхода для определения, является ли количество второй хромосомы или сегмента хромосомы, определенное на этапе (d), с большей вероятностью частью распределения, рассчитанного на этапе (f), или распределения, рассчитанного на этапе (g); что, тем самым, указывает на наличие или отсутствие анеуплоидии у плода.
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161462972P | 2011-02-09 | 2011-02-09 | |
US61/462,972 | 2011-02-09 | ||
US201161448547P | 2011-03-02 | 2011-03-02 | |
US61/448,547 | 2011-03-02 | ||
US201161516996P | 2011-04-12 | 2011-04-12 | |
US61/516,996 | 2011-04-12 | ||
US13/110,685 US8825412B2 (en) | 2010-05-18 | 2011-05-18 | Methods for non-invasive prenatal ploidy calling |
US13/110,685 | 2011-05-18 | ||
US201161571248P | 2011-06-23 | 2011-06-23 | |
US61/571,248 | 2011-06-23 | ||
US201161542508P | 2011-10-03 | 2011-10-03 | |
US61/542,508 | 2011-10-03 | ||
US13/300,235 | 2011-11-18 | ||
PCT/US2011/061506 WO2012108920A1 (en) | 2011-02-09 | 2011-11-18 | Methods for non-invasive prenatal ploidy calling |
US13/300,235 US10017812B2 (en) | 2010-05-18 | 2011-11-18 | Methods for non-invasive prenatal ploidy calling |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013141237A true RU2013141237A (ru) | 2015-03-20 |
RU2671980C2 RU2671980C2 (ru) | 2018-11-08 |
Family
ID=46638881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013141237A RU2671980C2 (ru) | 2011-02-09 | 2011-11-18 | Способы неинвазивного пренатального установления плоидности |
Country Status (10)
Country | Link |
---|---|
US (16) | US10017812B2 (ru) |
EP (1) | EP2673729B1 (ru) |
JP (1) | JP6153874B2 (ru) |
CN (1) | CN103608818B (ru) |
AU (1) | AU2011358564B9 (ru) |
BR (1) | BR112013020220B1 (ru) |
CA (1) | CA2824387C (ru) |
IL (1) | IL227842A0 (ru) |
RU (1) | RU2671980C2 (ru) |
WO (1) | WO2012108920A1 (ru) |
Families Citing this family (161)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070027636A1 (en) * | 2005-07-29 | 2007-02-01 | Matthew Rabinowitz | System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions |
US8532930B2 (en) * | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8515679B2 (en) * | 2005-12-06 | 2013-08-20 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US20070178501A1 (en) * | 2005-12-06 | 2007-08-02 | Matthew Rabinowitz | System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US20110033862A1 (en) * | 2008-02-19 | 2011-02-10 | Gene Security Network, Inc. | Methods for cell genotyping |
US20110092763A1 (en) * | 2008-05-27 | 2011-04-21 | Gene Security Network, Inc. | Methods for Embryo Characterization and Comparison |
CA2731991C (en) * | 2008-08-04 | 2021-06-08 | Gene Security Network, Inc. | Methods for allele calling and ploidy calling |
EP2425240A4 (en) | 2009-04-30 | 2012-12-12 | Good Start Genetics Inc | METHOD AND COMPOSITION FOR EVALUATING GENETIC MARKERS |
US10017812B2 (en) | 2010-05-18 | 2018-07-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
EP2473638B1 (en) | 2009-09-30 | 2017-08-09 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
CA2786565C (en) | 2010-01-19 | 2017-04-25 | Verinata Health, Inc. | Partition defined detection methods |
WO2011090559A1 (en) | 2010-01-19 | 2011-07-28 | Verinata Health, Inc. | Sequencing methods and compositions for prenatal diagnoses |
US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
EP2513341B1 (en) | 2010-01-19 | 2017-04-12 | Verinata Health, Inc | Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing |
US20120100548A1 (en) | 2010-10-26 | 2012-04-26 | Verinata Health, Inc. | Method for determining copy number variations |
US9323888B2 (en) | 2010-01-19 | 2016-04-26 | Verinata Health, Inc. | Detecting and classifying copy number variation |
US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
EP2572003A4 (en) | 2010-05-18 | 2016-01-13 | Natera Inc | METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
CN103608466B (zh) | 2010-12-22 | 2020-09-18 | 纳特拉公司 | 非侵入性产前亲子鉴定方法 |
US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
WO2016100976A2 (en) * | 2014-12-19 | 2016-06-23 | Apprise Bio, Inc. | Methods for identifying multiple epitopes in selected sub-populations of cells |
US11560585B2 (en) | 2011-01-31 | 2023-01-24 | Roche Sequencing Solutions, Inc. | Methods of identifying multiple epitopes in cells |
JP6069224B2 (ja) | 2011-01-31 | 2017-02-01 | アプライズ バイオ, インコーポレイテッド | 細胞において複数のエピトープを同定する方法 |
AU2012311262C1 (en) * | 2011-02-24 | 2017-06-29 | The Chinese University Of Hong Kong | Molecular testing of multiple pregnancies |
DK3456844T3 (da) * | 2011-04-12 | 2020-06-29 | Verinata Health Inc | Bestemmelse af genomfraktioner under anvendelse af polymorfisme-tællinger |
US9411937B2 (en) | 2011-04-15 | 2016-08-09 | Verinata Health, Inc. | Detecting and classifying copy number variation |
WO2012177792A2 (en) | 2011-06-24 | 2012-12-27 | Sequenom, Inc. | Methods and processes for non-invasive assessment of a genetic variation |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20140242588A1 (en) | 2011-10-06 | 2014-08-28 | Sequenom, Inc | Methods and processes for non-invasive assessment of genetic variations |
US8688388B2 (en) | 2011-10-11 | 2014-04-01 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP2768983A4 (en) | 2011-10-17 | 2015-06-03 | Good Start Genetics Inc | METHODS OF IDENTIFYING MUTATIONS ASSOCIATED WITH DISEASES |
EP2769007B1 (en) | 2011-10-19 | 2016-12-07 | Nugen Technologies, Inc. | Compositions and methods for directional nucleic acid amplification and sequencing |
WO2013109981A1 (en) | 2012-01-20 | 2013-07-25 | Sequenom, Inc. | Diagnostic processes that factor experimental conditions |
EP3578697B1 (en) | 2012-01-26 | 2024-03-06 | Tecan Genomics, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
US10227635B2 (en) | 2012-04-16 | 2019-03-12 | Molecular Loop Biosolutions, Llc | Capture reactions |
US10385396B2 (en) | 2012-04-19 | 2019-08-20 | The Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free DNA |
US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
RU2014152211A (ru) * | 2012-05-23 | 2016-07-20 | БГИ Диагносис Ко., Лтд. | Способ и система идентификации типов близнецов |
US9193992B2 (en) * | 2012-06-05 | 2015-11-24 | Agilent Technologies, Inc. | Method for determining ploidy of a cell |
GB2518078B (en) | 2012-06-18 | 2015-04-29 | Nugen Technologies Inc | Compositions and methods for negative selection of non-desired nucleic acid sequences |
US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
AU2012385961B9 (en) | 2012-07-24 | 2017-05-18 | Natera, Inc. | Highly multiplex PCR methods and compositions |
US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
KR20240007774A (ko) | 2012-09-04 | 2024-01-16 | 가던트 헬쓰, 인크. | 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법 |
US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20140242581A1 (en) * | 2013-01-23 | 2014-08-28 | Reproductive Genetics And Technology Solutions, Llc | Compositions and methods for genetic analysis of embryos |
US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10844424B2 (en) | 2013-02-20 | 2020-11-24 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
CN105229168B (zh) | 2013-02-20 | 2020-07-17 | 生物纳米基因有限公司 | 纳米流体中分子的表征 |
US9235808B2 (en) | 2013-03-14 | 2016-01-12 | International Business Machines Corporation | Evaluation of predictions in the absence of a known ground truth |
EP2971159B1 (en) | 2013-03-14 | 2019-05-08 | Molecular Loop Biosolutions, LLC | Methods for analyzing nucleic acids |
WO2014143989A1 (en) * | 2013-03-15 | 2014-09-18 | Medical College Of Wisconsin, Inc. | Fetal well being surveillance using fetal specific cell free dna |
WO2014144092A1 (en) | 2013-03-15 | 2014-09-18 | Nugen Technologies, Inc. | Sequential sequencing |
US10930368B2 (en) | 2013-04-03 | 2021-02-23 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CA2910205C (en) | 2013-05-24 | 2023-04-04 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20140371078A1 (en) * | 2013-06-17 | 2014-12-18 | Verinata Health, Inc. | Method for determining copy number variations in sex chromosomes |
TR201904345T4 (tr) | 2013-06-21 | 2019-04-22 | Sequenom Inc | Genetik Varyasyonları Non-İnvazif Değerlendirme Yöntemi |
WO2015026967A1 (en) * | 2013-08-20 | 2015-02-26 | Natera, Inc. | Methods of using low fetal fraction detection |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
US9499870B2 (en) | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
CA3205430A1 (en) | 2013-10-04 | 2015-04-09 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP3851539A1 (en) | 2013-10-07 | 2021-07-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of chromosome alterations |
US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
CA2929596C (en) | 2013-11-13 | 2022-07-05 | Nugen Technologies, Inc. | Compositions and methods for identification of a duplicate sequencing read |
CN111534580A (zh) | 2013-12-28 | 2020-08-14 | 夸登特健康公司 | 用于检测遗传变异的方法和系统 |
CN104745679B (zh) * | 2013-12-31 | 2018-06-15 | 杭州贝瑞和康基因诊断技术有限公司 | 一种无创检测egfr基因突变的方法及试剂盒 |
CN106164295B (zh) * | 2014-02-25 | 2020-08-11 | 生物纳米基因公司 | 减小基因组覆盖测量中的偏差 |
WO2015131107A1 (en) | 2014-02-28 | 2015-09-03 | Nugen Technologies, Inc. | Reduced representation bisulfite sequencing with diversity adaptors |
CN103901217A (zh) * | 2014-03-21 | 2014-07-02 | 靖江市人民医院 | 大豆过氧化物酶免疫生物芯片及在唐氏综合症产前筛查血清学标志物检测中的应用 |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
WO2015171656A1 (en) * | 2014-05-06 | 2015-11-12 | Baylor College Of Medicine | Methods of linearly amplifying whole genome of a single cell |
US11053548B2 (en) | 2014-05-12 | 2021-07-06 | Good Start Genetics, Inc. | Methods for detecting aneuploidy |
US20160145684A1 (en) * | 2014-06-27 | 2016-05-26 | Genotox Laboratories | Methods of detecting synthetic urine and matching a urine sample to a subject |
CN104156631B (zh) * | 2014-07-14 | 2017-07-18 | 天津华大基因科技有限公司 | 染色体三倍体检验方法 |
US10119167B2 (en) | 2014-07-18 | 2018-11-06 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA |
US20160034640A1 (en) | 2014-07-30 | 2016-02-04 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
KR20170036727A (ko) * | 2014-08-01 | 2017-04-03 | 아리오사 다이어그노스틱스, 아이엔씨. | 혼성화를 이용한 표적 핵산 검출 방법 |
US20160053301A1 (en) * | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
US11408024B2 (en) | 2014-09-10 | 2022-08-09 | Molecular Loop Biosciences, Inc. | Methods for selectively suppressing non-target sequences |
EP3192879A1 (en) * | 2014-09-11 | 2017-07-19 | Fujifilm Corporation | Method for detecting presence/absence of fetal chromosomal aneuploidy |
WO2016042830A1 (ja) * | 2014-09-16 | 2016-03-24 | 富士フイルム株式会社 | 胎児染色体の解析方法 |
US20160085910A1 (en) * | 2014-09-18 | 2016-03-24 | Illumina, Inc. | Methods and systems for analyzing nucleic acid sequencing data |
US10612080B2 (en) * | 2014-09-22 | 2020-04-07 | Roche Molecular Systems, Inc. | Digital PCR for non-invasive prenatal testing |
EP3224595A4 (en) | 2014-09-24 | 2018-06-13 | Good Start Genetics, Inc. | Process control for increased robustness of genetic assays |
JP2016067268A (ja) * | 2014-09-29 | 2016-05-09 | 富士フイルム株式会社 | 胎児の染色体異数性の非侵襲的判別方法 |
JP2017530720A (ja) * | 2014-10-17 | 2017-10-19 | グッド スタート ジェネティクス, インコーポレイテッド | 着床前遺伝子スクリーニングおよび異数性検出 |
WO2016068245A1 (ja) * | 2014-10-30 | 2016-05-06 | 株式会社 東芝 | 遺伝子型推定装置、方法、及びプログラム |
CA3010579A1 (en) | 2015-01-06 | 2016-07-14 | Good Start Genetics, Inc. | Screening for structural variants |
GB201502447D0 (en) | 2015-02-13 | 2015-04-01 | Univ Liverpool | Method and apparatus for sample analysis |
EP3279339B1 (en) | 2015-03-31 | 2020-08-26 | FUJIFILM Corporation | Method for determining gene state of fetus |
CN106148323B (zh) * | 2015-04-22 | 2021-03-05 | 北京贝瑞和康生物技术有限公司 | 一种用于构建alk基因融合突变检测文库的方法和试剂盒 |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
JP6913089B2 (ja) | 2015-11-11 | 2021-08-04 | レゾリューション バイオサイエンス, インコーポレイテッド | Dnaライブラリーの高効率構築 |
CA3008651A1 (en) | 2015-12-17 | 2017-06-22 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free dna |
NZ745249A (en) * | 2016-02-12 | 2021-07-30 | Regeneron Pharma | Methods and systems for detection of abnormal karyotypes |
AU2017290809A1 (en) * | 2016-07-01 | 2018-12-13 | Natera, Inc. | Compositions and methods for detection of nucleic acid mutations |
CA3030890A1 (en) | 2016-07-27 | 2018-02-01 | Sequenom, Inc. | Genetic copy number alteration classifications |
BR112019003704A2 (pt) | 2016-08-25 | 2019-05-28 | Resolution Bioscience Inc | métodos para a detecção de alterações na cópia genômica em amostras de dna |
US11854666B2 (en) | 2016-09-29 | 2023-12-26 | Myriad Women's Health, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
JPWO2018061674A1 (ja) * | 2016-09-30 | 2019-07-04 | 富士フイルム株式会社 | 脊椎動物由来の単一細胞の塩基配列情報を取得する方法 |
JP6560465B1 (ja) * | 2016-09-30 | 2019-08-21 | ガーダント ヘルス, インコーポレイテッド | 無細胞核酸の多重解像度分析のための方法 |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US10451544B2 (en) | 2016-10-11 | 2019-10-22 | Genotox Laboratories | Methods of characterizing a urine sample |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
WO2018140521A1 (en) | 2017-01-24 | 2018-08-02 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
WO2018145005A1 (en) * | 2017-02-03 | 2018-08-09 | Streck, Inc. | Sample collection tube with preservative |
WO2018156418A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
RU2657769C1 (ru) * | 2017-05-31 | 2018-06-15 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ прогнозирования наличия хромосомных аномалий в эмбрионах удовлетворительного и плохого качества на основании оценки транскрипционного профиля в кумулюсных клетках в программе экстракорпорального оплодотворения |
CA3067637A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free dna |
EP3649258B1 (en) * | 2017-07-07 | 2022-05-04 | Nipd Genetics Public Company Limited | Target-enriched multiplexed parallel analysis for assessment of fetal dna samples |
CN111433855A (zh) * | 2017-07-18 | 2020-07-17 | 康捷尼科有限公司 | 筛查系统和方法 |
WO2019020180A1 (en) * | 2017-07-26 | 2019-01-31 | Trisomytest, S.R.O. | METHOD FOR NON-EFFECTIVE PRENATAL DETECTION OF FETAL CHROMOSOMAL ANEUPLOIDIE FROM MATERNAL BLOOD ON THE BASIS OF A BAYESIAN NETWORK |
US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
KR20200085783A (ko) | 2017-10-27 | 2020-07-15 | 주노 다이어그노스틱스, 인크. | 초저용량 액체 생검을 위한 장치, 시스템 및 방법 |
CA3090426A1 (en) | 2018-04-14 | 2019-10-17 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
EP3818177A1 (en) | 2018-07-03 | 2021-05-12 | Natera, Inc. | Methods for detection of donor-derived cell-free dna |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CN109493919B (zh) * | 2018-10-31 | 2023-04-14 | 中国石油大学(华东) | 基于条件概率的基因型指派方法 |
WO2020118046A1 (en) * | 2018-12-05 | 2020-06-11 | William Marsh Rice University | Quantifying foreign dna in low-volume blood samples using snp profiling |
EP3899030A2 (en) | 2018-12-17 | 2021-10-27 | Natera, Inc. | Methods for analysis of circulating cells |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
EP3956466A1 (en) | 2019-04-15 | 2022-02-23 | Natera, Inc. | Improved liquid biopsy using size selection |
EP3980559A1 (en) | 2019-06-06 | 2022-04-13 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
WO2020257719A1 (en) * | 2019-06-21 | 2020-12-24 | Coopersurgical, Inc. | Systems and methods for determining genome ploidy |
JP2023528777A (ja) | 2020-05-29 | 2023-07-06 | ナテラ,インク. | ドナー由来無細胞dnaの検出方法 |
CN111951890B (zh) * | 2020-08-13 | 2022-03-22 | 北京博昊云天科技有限公司 | 染色体和单基因病同步产前筛查的设备、试剂盒和分析系统 |
AU2021358892A1 (en) * | 2020-10-05 | 2023-06-08 | Twist Bioscience Corporation | Hybridization methods and reagents |
JP2024507536A (ja) | 2021-02-25 | 2024-02-20 | ナテラ, インコーポレイテッド | 複数の臓器の移植レシピエントにおけるドナー由来無細胞dnaの検出方法 |
EP4308722A1 (en) | 2021-03-18 | 2024-01-24 | Natera, Inc. | Methods for determination of transplant rejection |
WO2022225933A1 (en) | 2021-04-22 | 2022-10-27 | Natera, Inc. | Methods for determining velocity of tumor growth |
AU2022323972A1 (en) | 2021-08-02 | 2024-01-25 | Natera, Inc. | Methods for detecting neoplasm in pregnant women |
WO2023034090A1 (en) | 2021-09-01 | 2023-03-09 | Natera, Inc. | Methods for non-invasive prenatal testing |
WO2023129936A1 (en) * | 2021-12-29 | 2023-07-06 | AiOnco, Inc. | System and method for text-based biological information processing with analysis refinement |
WO2023133131A1 (en) | 2022-01-04 | 2023-07-13 | Natera, Inc. | Methods for cancer detection and monitoring |
WO2023244735A2 (en) | 2022-06-15 | 2023-12-21 | Natera, Inc. | Methods for determination and monitoring of transplant rejection by measuring rna |
WO2024006373A1 (en) | 2022-06-29 | 2024-01-04 | Natera, Inc. | Compositions and methods for identification of chromosomal microdeletions |
Family Cites Families (265)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153117A (en) | 1990-03-27 | 1992-10-06 | Genetype A.G. | Fetal cell recovery method |
US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
IL103935A0 (en) | 1991-12-04 | 1993-05-13 | Du Pont | Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification |
GB9305984D0 (en) | 1993-03-23 | 1993-05-12 | Royal Free Hosp School Med | Predictive assay |
WO1995006137A1 (en) | 1993-08-27 | 1995-03-02 | Australian Red Cross Society | Detection of genes |
US5716776A (en) | 1994-03-04 | 1998-02-10 | Mark H. Bogart | Enrichment by preferential mitosis of fetal lymphocytes from a maternal blood sample |
US6025128A (en) | 1994-09-29 | 2000-02-15 | The University Of Tulsa | Prediction of prostate cancer progression by analysis of selected predictive parameters |
US6479235B1 (en) | 1994-09-30 | 2002-11-12 | Promega Corporation | Multiplex amplification of short tandem repeat loci |
US6720140B1 (en) | 1995-06-07 | 2004-04-13 | Invitrogen Corporation | Recombinational cloning using engineered recombination sites |
US5733729A (en) | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
US6852487B1 (en) | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US6108635A (en) | 1996-05-22 | 2000-08-22 | Interleukin Genetics, Inc. | Integrated disease information system |
US6100029A (en) | 1996-08-14 | 2000-08-08 | Exact Laboratories, Inc. | Methods for the detection of chromosomal aberrations |
US6300077B1 (en) | 1996-08-14 | 2001-10-09 | Exact Sciences Corporation | Methods for the detection of nucleic acids |
US6221654B1 (en) | 1996-09-25 | 2001-04-24 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US5860917A (en) | 1997-01-15 | 1999-01-19 | Chiron Corporation | Method and apparatus for predicting therapeutic outcomes |
US5824467A (en) | 1997-02-25 | 1998-10-20 | Celtrix Pharmaceuticals | Methods for predicting drug response |
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
ES2230631T3 (es) | 1997-03-20 | 2005-05-01 | F. Hoffmann-La Roche Ag | Cebadores modificados. |
US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
US5994148A (en) | 1997-06-23 | 1999-11-30 | The Regents Of University Of California | Method of predicting and enhancing success of IVF/ET pregnancy |
US6013444A (en) * | 1997-09-18 | 2000-01-11 | Oligotrail, Llc | DNA bracketing locus compatible standards for electrophoresis |
US6833242B2 (en) | 1997-09-23 | 2004-12-21 | California Institute Of Technology | Methods for detecting and sorting polynucleotides based on size |
US6180349B1 (en) | 1999-05-18 | 2001-01-30 | The Regents Of The University Of California | Quantitative PCR method to enumerate DNA copy number |
US7058517B1 (en) | 1999-06-25 | 2006-06-06 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
US6964847B1 (en) | 1999-07-14 | 2005-11-15 | Packard Biosciences Company | Derivative nucleic acids and uses thereof |
GB9917307D0 (en) | 1999-07-23 | 1999-09-22 | Sec Dep Of The Home Department | Improvements in and relating to analysis of DNA |
US6440706B1 (en) | 1999-08-02 | 2002-08-27 | Johns Hopkins University | Digital amplification |
US6251604B1 (en) | 1999-08-13 | 2001-06-26 | Genopsys, Inc. | Random mutagenesis and amplification of nucleic acid |
US7510834B2 (en) | 2000-04-13 | 2009-03-31 | Hidetoshi Inoko | Gene mapping method using microsatellite genetic polymorphism markers |
GB0009179D0 (en) | 2000-04-13 | 2000-05-31 | Imp College Innovations Ltd | Non-invasive prenatal diagnosis |
AU2001274869A1 (en) | 2000-05-20 | 2001-12-03 | The Regents Of The University Of Michigan | Method of producing a dna library using positional amplification |
AU2001264811A1 (en) | 2000-05-23 | 2001-12-03 | Vincent P. Stanton Jr. | Methods for genetic analysis of dna to detect sequence variances |
WO2001094630A2 (en) | 2000-06-07 | 2001-12-13 | Baylor College Of Medicine | Compositions and methods for array-based nucleic acid hybridization |
US7058616B1 (en) | 2000-06-08 | 2006-06-06 | Virco Bvba | Method and system for predicting resistance of a disease to a therapeutic agent using a neural network |
GB0016742D0 (en) | 2000-07-10 | 2000-08-30 | Simeg Limited | Diagnostic method |
US20020107640A1 (en) | 2000-11-14 | 2002-08-08 | Ideker Trey E. | Methods for determining the true signal of an analyte |
WO2002055985A2 (en) | 2000-11-15 | 2002-07-18 | Roche Diagnostics Corp | Methods and reagents for identifying rare fetal cells in the material circulation |
US7218764B2 (en) | 2000-12-04 | 2007-05-15 | Cytokinetics, Inc. | Ploidy classification method |
WO2002073504A1 (en) | 2001-03-14 | 2002-09-19 | Gene Logic, Inc. | A system and method for retrieving and using gene expression data from multiple sources |
US6489135B1 (en) | 2001-04-17 | 2002-12-03 | Atairgintechnologies, Inc. | Determination of biological characteristics of embryos fertilized in vitro by assaying for bioactive lipids in culture media |
FR2824144B1 (fr) | 2001-04-30 | 2004-09-17 | Metagenex S A R L | Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel |
WO2002087431A1 (en) | 2001-05-01 | 2002-11-07 | Structural Bioinformatics, Inc. | Diagnosing inapparent diseases from common clinical tests using bayesian analysis |
US20030101000A1 (en) | 2001-07-24 | 2003-05-29 | Bader Joel S. | Family based tests of association using pooled DNA and SNP markers |
US6958211B2 (en) | 2001-08-08 | 2005-10-25 | Tibotech Bvba | Methods of assessing HIV integrase inhibitor therapy |
US6807491B2 (en) | 2001-08-30 | 2004-10-19 | Hewlett-Packard Development Company, L.P. | Method and apparatus for combining gene predictions using bayesian networks |
AUPR749901A0 (en) | 2001-09-06 | 2001-09-27 | Monash University | Method of identifying chromosomal abnormalities and prenatal diagnosis |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
EP1442139A4 (en) | 2001-10-12 | 2005-01-26 | Univ Queensland | SELECTION AND AMPLIFICATION OF MULTIPLE GENETIC MARKERS |
US7297485B2 (en) | 2001-10-15 | 2007-11-20 | Qiagen Gmbh | Method for nucleic acid amplification that results in low amplification bias |
US20030119004A1 (en) | 2001-12-05 | 2003-06-26 | Wenz H. Michael | Methods for quantitating nucleic acids using coupled ligation and amplification |
CA2469878C (en) | 2001-12-11 | 2011-06-28 | Netech Inc. | Blood cell separating system |
US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
US7035739B2 (en) | 2002-02-01 | 2006-04-25 | Rosetta Inpharmatics Llc | Computer systems and methods for identifying genes and determining pathways associated with traits |
CA2477611A1 (en) | 2002-03-01 | 2003-09-12 | Ravgen, Inc. | Rapid analysis of variations in a genome |
US6977162B2 (en) | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
US20060229823A1 (en) | 2002-03-28 | 2006-10-12 | Affymetrix, Inc. | Methods and computer software products for analyzing genotyping data |
US7208317B2 (en) | 2002-05-02 | 2007-04-24 | The University Of North Carolina At Chapel Hill | In Vitro mutagenesis, phenotyping, and gene mapping |
US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
US7442506B2 (en) | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
US20070178478A1 (en) | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
US20040229231A1 (en) | 2002-05-28 | 2004-11-18 | Frudakis Tony N. | Compositions and methods for inferring ancestry |
NZ537328A (en) | 2002-05-31 | 2008-04-30 | Genetic Technologies Ltd | Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
WO2003106623A2 (en) | 2002-06-13 | 2003-12-24 | New York University | Early noninvasive prenatal test for aneuploidies and heritable conditions |
US20050009069A1 (en) | 2002-06-25 | 2005-01-13 | Affymetrix, Inc. | Computer software products for analyzing genotyping |
US7459273B2 (en) | 2002-10-04 | 2008-12-02 | Affymetrix, Inc. | Methods for genotyping selected polymorphism |
AU2003285861A1 (en) | 2002-10-07 | 2004-05-04 | University Of Medicine And Dentistry Of New Jersey | High throughput multiplex dna sequence amplifications |
WO2004044225A2 (en) | 2002-11-11 | 2004-05-27 | Affymetrix, Inc. | Methods for identifying dna copy number changes |
CA2513302C (en) | 2003-01-17 | 2013-03-26 | The Trustees Of Boston University | Haplotype analysis |
WO2004065628A1 (en) | 2003-01-21 | 2004-08-05 | Guoliang Fu | Quantitative multiplex detection of nucleic acids |
DE602004024034D1 (de) | 2003-01-29 | 2009-12-24 | 454 Corp | Nukleinsäureamplifikation auf basis von kügelchenemulsion |
WO2004081183A2 (en) | 2003-03-07 | 2004-09-23 | Rubicon Genomics, Inc. | In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna |
US20040197832A1 (en) | 2003-04-03 | 2004-10-07 | Mor Research Applications Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
BRPI0410656A (pt) | 2003-05-28 | 2006-07-18 | Pioneer Hi Bred Int | método de melhoramento de planta e planta obtida |
US20040259100A1 (en) | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
AU2003263660A1 (en) | 2003-08-29 | 2005-03-16 | Pantarhei Bioscience B.V. | Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood |
WO2005023091A2 (en) | 2003-09-05 | 2005-03-17 | The Trustees Of Boston University | Method for non-invasive prenatal diagnosis |
JP5013869B2 (ja) * | 2003-09-22 | 2012-08-29 | トリソゲン バイオテクノロジー リミテッド パートナーシップ | 遺伝子座コピー数の変化を検出するのに有用な方法およびキット |
JPWO2005028645A1 (ja) | 2003-09-24 | 2007-11-15 | 株式会社産学連携機構九州 | MDR1遺伝子の5’制御領域におけるSNPs |
CN101985619B (zh) | 2003-10-08 | 2014-08-20 | 波士顿大学信托人 | 染色体异常的产前诊断方法 |
CA2482097C (en) | 2003-10-13 | 2012-02-21 | F. Hoffmann-La Roche Ag | Methods for isolating nucleic acids |
ATE435301T1 (de) | 2003-10-16 | 2009-07-15 | Sequenom Inc | Nicht invasiver nachweis fötaler genetischer merkmale |
US20050221341A1 (en) | 2003-10-22 | 2005-10-06 | Shimkets Richard A | Sequence-based karyotyping |
EP1678329A4 (en) | 2003-10-30 | 2008-07-02 | Tufts New England Medical Ct | PRENATAL DIAGNOSIS USING CELL-FREE FEDERAL DNA IN FRUIT WATER |
WO2005071078A1 (en) | 2004-01-12 | 2005-08-04 | Nimblegen Systems Inc. | Method of performing pcr amplification on a microarray |
US20100216153A1 (en) | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
US7035740B2 (en) | 2004-03-24 | 2006-04-25 | Illumina, Inc. | Artificial intelligence and global normalization methods for genotyping |
JP4437050B2 (ja) | 2004-03-26 | 2010-03-24 | 株式会社日立製作所 | 診断支援システム、診断支援方法および診断支援サービスの提供方法 |
US7805282B2 (en) * | 2004-03-30 | 2010-09-28 | New York University | Process, software arrangement and computer-accessible medium for obtaining information associated with a haplotype |
JP4756032B2 (ja) | 2004-03-31 | 2011-08-24 | アトナーゲン アクチエンゲゼルシャフト | 胎児赤血球細胞に対して特異性を有するモノクローナル抗体 |
US7414118B1 (en) | 2004-04-14 | 2008-08-19 | Applied Biosystems Inc. | Modified oligonucleotides and applications thereof |
US7468249B2 (en) | 2004-05-05 | 2008-12-23 | Biocept, Inc. | Detection of chromosomal disorders |
US7709194B2 (en) | 2004-06-04 | 2010-05-04 | The Chinese University Of Hong Kong | Marker for prenatal diagnosis and monitoring |
JP2008506637A (ja) | 2004-06-14 | 2008-03-06 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | 胎児起源の細胞に対する抗体 |
EP1786924A4 (en) | 2004-07-06 | 2008-10-01 | Genera Biosystems Pty Ltd | METHOD FOR DETECTING ANEUPLOIDIA |
DE102004036285A1 (de) | 2004-07-27 | 2006-02-16 | Advalytix Ag | Verfahren zum Bestimmen der Häufigkeit von Sequenzen einer Probe |
US20060040300A1 (en) | 2004-08-09 | 2006-02-23 | Generation Biotech, Llc | Method for nucleic acid isolation and amplification |
WO2006023769A2 (en) | 2004-08-18 | 2006-03-02 | Abbott Molecular, Inc. | Determining data quality and/or segmental aneusomy using a computer system |
US8024128B2 (en) | 2004-09-07 | 2011-09-20 | Gene Security Network, Inc. | System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data |
US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
US20060134662A1 (en) | 2004-10-25 | 2006-06-22 | Pratt Mark R | Method and system for genotyping samples in a normalized allelic space |
CA2585784A1 (en) | 2004-11-17 | 2006-05-26 | Mosaic Reproductive Health And Genetics, Llc | Methods of determining human egg competency |
US20070042384A1 (en) | 2004-12-01 | 2007-02-22 | Weiwei Li | Method for isolating and modifying DNA from blood and body fluids |
WO2006084391A1 (en) * | 2005-02-11 | 2006-08-17 | Smartgene Gmbh | Computer-implemented method and computer-based system for validating dna sequencing data |
WO2006091979A2 (en) | 2005-02-25 | 2006-08-31 | The Regents Of The University Of California | Full karyotype single cell chromosome analysis |
US7618777B2 (en) | 2005-03-16 | 2009-11-17 | Agilent Technologies, Inc. | Composition and method for array hybridization |
ES2398233T3 (es) | 2005-03-18 | 2013-03-14 | The Chinese University Of Hong Kong | Un método para la detección de aneuploidías cromosómicas |
US7718367B2 (en) | 2005-03-18 | 2010-05-18 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
WO2006102569A2 (en) * | 2005-03-24 | 2006-09-28 | Zoragen Biotechnologies Llp | Nucleic acid detection |
US20070020640A1 (en) | 2005-07-21 | 2007-01-25 | Mccloskey Megan L | Molecular encoding of nucleic acid templates for PCR and other forms of sequence analysis |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US20070027636A1 (en) | 2005-07-29 | 2007-02-01 | Matthew Rabinowitz | System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions |
US20070178501A1 (en) | 2005-12-06 | 2007-08-02 | Matthew Rabinowitz | System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology |
US11111543B2 (en) * | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8532930B2 (en) * | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
US8515679B2 (en) | 2005-12-06 | 2013-08-20 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
GB0523276D0 (en) | 2005-11-15 | 2005-12-21 | London Bridge Fertility | Chromosomal analysis by molecular karyotyping |
JP6121642B2 (ja) | 2005-11-26 | 2017-04-26 | ナテラ, インコーポレイテッド | 予測を行うための、遺伝子データを清浄化し、そして、そのデータを使用するためのシステムおよび方法 |
WO2007070482A2 (en) | 2005-12-14 | 2007-06-21 | Xueliang Xia | Microarray-based preimplantation genetic diagnosis of chromosomal abnormalities |
LT2385143T (lt) | 2006-02-02 | 2016-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Neinvazinė vaisiaus genetinė atranka pasitelkiant skaitmeninę analizę |
WO2007092538A2 (en) * | 2006-02-07 | 2007-08-16 | President And Fellows Of Harvard College | Methods for making nucleotide probes for sequencing and synthesis |
US9012184B2 (en) | 2006-02-08 | 2015-04-21 | Illumina Cambridge Limited | End modification to prevent over-representation of fragments |
SI2351858T1 (sl) | 2006-02-28 | 2015-06-30 | University Of Louisville Research Foundation Med Center Three, | Zaznavanje fetalnih kromosomskih nenormalnosti z uporabo tandema polimorfizmov posameznih nukleotidov |
US20080038733A1 (en) | 2006-03-28 | 2008-02-14 | Baylor College Of Medicine | Screening for down syndrome |
US20070243549A1 (en) | 2006-04-12 | 2007-10-18 | Biocept, Inc. | Enrichment of circulating fetal dna |
US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
US7901884B2 (en) | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
EP2029779A4 (en) | 2006-06-14 | 2010-01-20 | Living Microsystems Inc | HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS |
WO2009035447A1 (en) | 2006-06-14 | 2009-03-19 | Living Microsystems, Inc. | Diagnosis of fetal abnormalities by comparative genomic hybridization analysis |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
CN101675169B (zh) | 2006-06-14 | 2018-01-02 | 维里纳塔健康公司 | 使用样品拆分和dna标签进行稀有细胞分析 |
US20080090239A1 (en) | 2006-06-14 | 2008-04-17 | Daniel Shoemaker | Rare cell analysis using sample splitting and dna tags |
WO2007149791A2 (en) | 2006-06-15 | 2007-12-27 | Stratagene | System for isolating biomolecules from a sample |
US20080182244A1 (en) | 2006-08-04 | 2008-07-31 | Ikonisys, Inc. | Pre-Implantation Genetic Diagnosis Test |
EP2054719B1 (en) * | 2006-08-22 | 2014-07-23 | The Government of the United States of America as represented by the Secretary of the Navy | Design and selection of genetic targets for sequence resolved organism detection and identification |
US9273309B2 (en) | 2006-08-24 | 2016-03-01 | University Of Massachusetts | Mapping of genomic interactions |
US9149473B2 (en) | 2006-09-14 | 2015-10-06 | Ibis Biosciences, Inc. | Targeted whole genome amplification method for identification of pathogens |
US20080085836A1 (en) | 2006-09-22 | 2008-04-10 | Kearns William G | Method for genetic testing of human embryos for chromosome abnormalities, segregating genetic disorders with or without a known mutation and mitochondrial disorders following in vitro fertilization (IVF), embryo culture and embryo biopsy |
WO2008048931A1 (en) | 2006-10-16 | 2008-04-24 | Celula Inc. | Methods and compositions for differential expansion of fetal cells in maternal blood and their use |
US20100184152A1 (en) | 2006-10-23 | 2010-07-22 | Vladislav Sandler | Target-oriented whole genome amplification of nucleic acids |
WO2008059578A1 (fr) | 2006-11-16 | 2008-05-22 | Olympus Corporation | Procédé d'amplification pcr multiplex |
WO2008081451A2 (en) | 2007-01-03 | 2008-07-10 | Monaliza Medical Ltd. | Methods and kits for analyzing genetic material of a fetus |
CN101790731B (zh) | 2007-03-16 | 2013-11-06 | 纳特拉公司 | 用于清除遗传数据干扰并确定染色体拷贝数的系统和方法 |
ITTO20070307A1 (it) | 2007-05-04 | 2008-11-05 | Silicon Biosystems Spa | Metodo e dispositivo per la diagnosi prenatale non-invasiva |
KR20100038330A (ko) | 2007-05-31 | 2010-04-14 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 입체구조적 방해 및 효소 관련 신호 증폭 기반의 고 특이성 및 고 민감도 검출 |
WO2008157264A2 (en) | 2007-06-15 | 2008-12-24 | Sequenom, Inc. | Combined methods for the detection of chromosomal aneuploidy |
US20090023190A1 (en) | 2007-06-20 | 2009-01-22 | Kai Qin Lao | Sequence amplification with loopable primers |
WO2009009769A2 (en) | 2007-07-11 | 2009-01-15 | Artemis Health, Inc. | Diagnosis of fetal abnormalities using nucleated red blood cells |
US20100112590A1 (en) | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
CA2693081C (en) * | 2007-07-23 | 2016-01-26 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
US20090053719A1 (en) | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
EP2191276B1 (en) | 2007-08-03 | 2013-11-20 | DKFZ Deutsches Krebsforschungszentrum | Method for prenatal diagnosis using exosomes and cd24 as a marker |
US9404150B2 (en) | 2007-08-29 | 2016-08-02 | Sequenom, Inc. | Methods and compositions for universal size-specific PCR |
WO2009032779A2 (en) | 2007-08-29 | 2009-03-12 | Sequenom, Inc. | Methods and compositions for the size-specific seperation of nucleic acid from a sample |
US8748100B2 (en) | 2007-08-30 | 2014-06-10 | The Chinese University Of Hong Kong | Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences |
ATE541946T1 (de) | 2007-09-07 | 2012-02-15 | Fluidigm Corp | Verfahren und system zur bestimmung von genkopiezahlvarianten |
US20110300608A1 (en) | 2007-09-21 | 2011-12-08 | Streck, Inc. | Nucleic acid isolation in preserved whole blood |
WO2009036525A2 (en) | 2007-09-21 | 2009-03-26 | Katholieke Universiteit Leuven | Tools and methods for genetic tests using next generation sequencing |
CA2705267C (en) | 2007-11-30 | 2018-07-31 | Ge Healthcare Bio-Sciences Corp. | Method for isolation of genomic dna, rna and proteins from a single sample |
EP2077337A1 (en) | 2007-12-26 | 2009-07-08 | Eppendorf Array Technologies SA | Amplification and detection composition, method and kit |
WO2009092035A2 (en) | 2008-01-17 | 2009-07-23 | Sequenom, Inc. | Methods and compositions for the analysis of biological molecules |
WO2009091934A1 (en) | 2008-01-17 | 2009-07-23 | Sequenom, Inc. | Single molecule nucleic acid sequence analysis processes and compositions |
US20110033862A1 (en) | 2008-02-19 | 2011-02-10 | Gene Security Network, Inc. | Methods for cell genotyping |
US20090221620A1 (en) | 2008-02-20 | 2009-09-03 | Celera Corporation | Gentic polymorphisms associated with stroke, methods of detection and uses thereof |
HUE029914T2 (en) | 2008-04-03 | 2017-04-28 | Cb Biotechnologies Inc | Amplicon-saving multiplex polymerase chain reaction for amplification of multiple targets |
US20110092763A1 (en) | 2008-05-27 | 2011-04-21 | Gene Security Network, Inc. | Methods for Embryo Characterization and Comparison |
CA2731991C (en) * | 2008-08-04 | 2021-06-08 | Gene Security Network, Inc. | Methods for allele calling and ploidy calling |
CA2734868C (en) | 2008-08-26 | 2019-09-10 | Fluidigm Corporation | Assay methods for increased throughput of samples and/or targets |
DE102008045705A1 (de) | 2008-09-04 | 2010-04-22 | Macherey, Nagel Gmbh & Co. Kg Handelsgesellschaft | Verfahren zur Gewinnung von kurzer RNA sowie Kit hierfür |
US8586310B2 (en) | 2008-09-05 | 2013-11-19 | Washington University | Method for multiplexed nucleic acid patch polymerase chain reaction |
WO2010033652A1 (en) | 2008-09-17 | 2010-03-25 | Ge Healthcare Bio-Sciences Corp. | Method for small rna isolation |
SI2562268T1 (sl) | 2008-09-20 | 2017-05-31 | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170 | Neinvazivna diagnoza fetalne anevploidije s sekvenciranjem |
CA2748030A1 (en) | 2008-12-22 | 2010-07-01 | Arnold R. Oliphant | Methods and genotyping panels for detecting alleles, genomes, and transcriptomes |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
WO2010088288A2 (en) | 2009-01-28 | 2010-08-05 | Fluidigm Corporation | Determination of copy number differences by amplification |
US8304187B2 (en) | 2009-02-18 | 2012-11-06 | Streck, Inc. | Preservation of cell-free RNA in blood samples |
US20100285537A1 (en) | 2009-04-02 | 2010-11-11 | Fluidigm Corporation | Selective tagging of short nucleic acid fragments and selective protection of target sequences from degradation |
WO2010127186A1 (en) | 2009-04-30 | 2010-11-04 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
US10017812B2 (en) * | 2010-05-18 | 2018-07-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20130196862A1 (en) | 2009-07-17 | 2013-08-01 | Natera, Inc. | Informatics Enhanced Analysis of Fetal Samples Subject to Maternal Contamination |
US8563242B2 (en) | 2009-08-11 | 2013-10-22 | The Chinese University Of Hong Kong | Method for detecting chromosomal aneuploidy |
US9238809B2 (en) | 2009-09-24 | 2016-01-19 | Qiagen Gaithersburg, Inc. | Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material |
EP2473638B1 (en) | 2009-09-30 | 2017-08-09 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
HRP20230134T1 (hr) | 2009-11-05 | 2023-03-31 | The Chinese University Of Hong Kong | Analiza genoma fetusa iz biološkog uzorka majke |
EP3719140A1 (en) * | 2009-11-06 | 2020-10-07 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive diagnosis of graft rejection in organ transplant patients |
WO2011066476A1 (en) | 2009-11-25 | 2011-06-03 | Quantalife, Inc. | Methods and compositions for detecting genetic material |
WO2011072086A1 (en) | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
US9315857B2 (en) | 2009-12-15 | 2016-04-19 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse label-tags |
US8574842B2 (en) | 2009-12-22 | 2013-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Direct molecular diagnosis of fetal aneuploidy |
US9926593B2 (en) | 2009-12-22 | 2018-03-27 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
WO2011090559A1 (en) | 2010-01-19 | 2011-07-28 | Verinata Health, Inc. | Sequencing methods and compositions for prenatal diagnoses |
US20120010085A1 (en) | 2010-01-19 | 2012-01-12 | Rava Richard P | Methods for determining fraction of fetal nucleic acids in maternal samples |
US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
WO2011142836A2 (en) * | 2010-05-14 | 2011-11-17 | Fluidigm Corporation | Assays for the detection of genotype, mutations, and/or aneuploidy |
WO2013052557A2 (en) | 2011-10-03 | 2013-04-11 | Natera, Inc. | Methods for preimplantation genetic diagnosis by sequencing |
US20130123120A1 (en) | 2010-05-18 | 2013-05-16 | Natera, Inc. | Highly Multiplex PCR Methods and Compositions |
US10316362B2 (en) * | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20140206552A1 (en) | 2010-05-18 | 2014-07-24 | Natera, Inc. | Methods for preimplantation genetic diagnosis by sequencing |
EP2572003A4 (en) | 2010-05-18 | 2016-01-13 | Natera Inc | METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20110301854A1 (en) | 2010-06-08 | 2011-12-08 | Curry Bo U | Method of Determining Allele-Specific Copy Number of a SNP |
US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US9267174B2 (en) * | 2010-10-26 | 2016-02-23 | Stanford University | Method of simultaneously screening for multiple genotypes and/or mutations |
TW202242133A (zh) | 2010-11-30 | 2022-11-01 | 香港中文大學 | 與癌症有關之基因或分子變異之檢測 |
WO2012078792A2 (en) | 2010-12-07 | 2012-06-14 | Stanford University | Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale |
US20150064695A1 (en) | 2010-12-17 | 2015-03-05 | Celula Inc. | Methods for screening and diagnosing genetic conditions |
CN103608466B (zh) | 2010-12-22 | 2020-09-18 | 纳特拉公司 | 非侵入性产前亲子鉴定方法 |
US20120190021A1 (en) | 2011-01-25 | 2012-07-26 | Aria Diagnostics, Inc. | Detection of genetic abnormalities |
EP3187597B1 (en) | 2011-02-09 | 2020-06-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
GB2488358A (en) | 2011-02-25 | 2012-08-29 | Univ Plymouth | Enrichment of foetal DNA in maternal plasma |
DK3456844T3 (da) | 2011-04-12 | 2020-06-29 | Verinata Health Inc | Bestemmelse af genomfraktioner under anvendelse af polymorfisme-tællinger |
WO2012142531A2 (en) | 2011-04-14 | 2012-10-18 | Complete Genomics, Inc. | Processing and analysis of complex nucleic acid sequence data |
CN103748236B (zh) | 2011-04-15 | 2018-12-25 | 约翰·霍普金斯大学 | 安全测序系统 |
US9957558B2 (en) | 2011-04-28 | 2018-05-01 | Life Technologies Corporation | Methods and compositions for multiplex PCR |
EP2546361B1 (en) | 2011-07-11 | 2015-06-03 | Samsung Electronics Co., Ltd. | Method of amplifying target nucleic acid with reduced amplification bias and method for determining relative amount of target nucleic acid in sample |
US20130024127A1 (en) | 2011-07-19 | 2013-01-24 | John Stuelpnagel | Determination of source contributions using binomial probability calculations |
GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
JP5536729B2 (ja) | 2011-09-20 | 2014-07-02 | 株式会社ソニー・コンピュータエンタテインメント | 情報処理装置、アプリケーション提供システム、アプリケーション提供サーバ、アプリケーション提供方法、および情報処理方法 |
EP4159857A1 (en) | 2011-09-26 | 2023-04-05 | QIAGEN GmbH | Rapid method for isolating extracellular nucleic acids |
WO2013078470A2 (en) | 2011-11-22 | 2013-05-30 | MOTIF, Active | Multiplex isolation of protein-associated nucleic acids |
US20140364439A1 (en) | 2011-12-07 | 2014-12-11 | The Broad Institute, Inc. | Markers associated with chronic lymphocytic leukemia prognosis and progression |
US20130190653A1 (en) | 2012-01-25 | 2013-07-25 | Angel Gabriel Alvarez Ramos | Device for blood collection from the placenta and the umbilical cord |
US9670529B2 (en) | 2012-02-28 | 2017-06-06 | Population Genetics Technologies Ltd. | Method for attaching a counter sequence to a nucleic acid sample |
WO2013130848A1 (en) | 2012-02-29 | 2013-09-06 | Natera, Inc. | Informatics enhanced analysis of fetal samples subject to maternal contamination |
EP4026912A1 (en) | 2012-05-10 | 2022-07-13 | The General Hospital Corporation | Methods for determining a nucleotide sequence |
WO2013177220A1 (en) | 2012-05-21 | 2013-11-28 | The Scripps Research Institute | Methods of sample preparation |
WO2014004726A1 (en) | 2012-06-26 | 2014-01-03 | Caifu Chen | Methods, compositions and kits for the diagnosis, prognosis and monitoring of cancer |
EP2877594B1 (en) | 2012-07-20 | 2019-12-04 | Verinata Health, Inc. | Detecting and classifying copy number variation in a fetal genome |
AU2012385961B9 (en) | 2012-07-24 | 2017-05-18 | Natera, Inc. | Highly multiplex PCR methods and compositions |
US20140051585A1 (en) | 2012-08-15 | 2014-02-20 | Natera, Inc. | Methods and compositions for reducing genetic library contamination |
US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
US20140065621A1 (en) | 2012-09-04 | 2014-03-06 | Natera, Inc. | Methods for increasing fetal fraction in maternal blood |
KR20240007774A (ko) | 2012-09-04 | 2024-01-16 | 가던트 헬쓰, 인크. | 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법 |
EP2943590A4 (en) | 2013-01-13 | 2017-02-15 | Unitaq Bio | Methods and compositions for pcr using blocked and universal primers |
ES2946689T3 (es) | 2013-03-15 | 2023-07-24 | Univ Leland Stanford Junior | Identificación y uso de marcadores tumorales de ácido nucleico circulante |
CN105408496A (zh) | 2013-03-15 | 2016-03-16 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
US10385394B2 (en) | 2013-03-15 | 2019-08-20 | The Translational Genomics Research Institute | Processes of identifying and characterizing X-linked disorders |
US20140272956A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Molecular Inc. | Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits |
US9499870B2 (en) | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
DK3077539T3 (en) | 2013-12-02 | 2018-11-19 | Personal Genome Diagnostics Inc | Procedure for evaluating minority variations in a sample |
CN111534580A (zh) | 2013-12-28 | 2020-08-14 | 夸登特健康公司 | 用于检测遗传变异的方法和系统 |
CA2938910A1 (en) | 2014-02-11 | 2015-08-20 | F. Hoffmann-La Roche Ag | Targeted sequencing and uid filtering |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
WO2015164432A1 (en) | 2014-04-21 | 2015-10-29 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
DK3164489T3 (da) | 2014-07-03 | 2020-08-10 | Rhodx Inc | Mærkning og vurdering af en målsekvens |
JP6689251B2 (ja) | 2014-07-17 | 2020-04-28 | キアゲン ゲーエムベーハー | Rnaを高収率で単離するための方法 |
US9783799B2 (en) | 2014-10-24 | 2017-10-10 | Abbott Molecular Inc. | Enrichment of small nucleic acids |
ES2906221T3 (es) | 2015-02-27 | 2022-04-13 | Becton Dickinson Co | Métodos para el marcado con códigos de barras de ácidos nucleicos para secuenciación |
ES2934982T3 (es) | 2015-03-30 | 2023-02-28 | Becton Dickinson Co | Métodos para la codificación con códigos de barras combinatorios |
CN107580632B (zh) | 2015-04-23 | 2021-12-28 | 贝克顿迪金森公司 | 用于全转录组扩增的方法和组合物 |
US10844428B2 (en) | 2015-04-28 | 2020-11-24 | Illumina, Inc. | Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS) |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
WO2018156418A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
-
2011
- 2011-11-18 US US13/300,235 patent/US10017812B2/en active Active
- 2011-11-18 WO PCT/US2011/061506 patent/WO2012108920A1/en active Application Filing
- 2011-11-18 CA CA2824387A patent/CA2824387C/en active Active
- 2011-11-18 RU RU2013141237A patent/RU2671980C2/ru active
- 2011-11-18 EP EP11858061.2A patent/EP2673729B1/en active Active
- 2011-11-18 JP JP2013553423A patent/JP6153874B2/ja active Active
- 2011-11-18 BR BR112013020220-3A patent/BR112013020220B1/pt active IP Right Grant
- 2011-11-18 AU AU2011358564A patent/AU2011358564B9/en active Active
- 2011-11-18 CN CN201180069972.0A patent/CN103608818B/zh active Active
-
2013
- 2013-03-08 US US13/791,397 patent/US9163282B2/en active Active
- 2013-08-07 IL IL227842A patent/IL227842A0/en unknown
-
2017
- 2017-05-03 US US15/586,013 patent/US20170242960A1/en not_active Abandoned
- 2017-10-06 US US15/727,428 patent/US20180025109A1/en not_active Abandoned
-
2018
- 2018-03-09 US US15/917,383 patent/US10174369B2/en active Active
-
2019
- 2019-02-28 US US16/289,049 patent/US20190211391A1/en not_active Abandoned
- 2019-02-28 US US16/289,528 patent/US20190249241A1/en not_active Abandoned
- 2019-03-21 US US16/360,843 patent/US20190203290A1/en not_active Abandoned
- 2019-03-22 US US16/361,511 patent/US20190211392A1/en active Pending
- 2019-03-22 US US16/361,611 patent/US20190211393A1/en not_active Abandoned
- 2019-04-30 US US16/399,794 patent/US20190256906A1/en not_active Abandoned
- 2019-04-30 US US16/399,991 patent/US20190256908A1/en active Granted
- 2019-05-02 US US16/401,535 patent/US20190256909A1/en not_active Abandoned
- 2019-05-28 US US16/424,290 patent/US20190360036A1/en active Pending
-
2020
- 2020-02-27 US US16/803,782 patent/US20200190573A1/en active Granted
-
2021
- 2021-07-16 US US17/377,802 patent/US20210355536A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013141237A (ru) | Способы неинвазивного пренатального установления плоидности | |
US11746376B2 (en) | Methods for amplification of cell-free DNA using ligated adaptors and universal and inner target-specific primers for multiplexed nested PCR | |
US11031100B2 (en) | Size-based sequencing analysis of cell-free tumor DNA for classifying level of cancer | |
US10774380B2 (en) | Methods for multiplex PCR amplification of target loci in a nucleic acid sample | |
JP6878631B2 (ja) | 非侵襲的に胎児の性染色体異数性のリスクを計算する方法 | |
US11326208B2 (en) | Methods for nested PCR amplification of cell-free DNA | |
US20180371539A1 (en) | Method of detecting a pre-determined event in a nucleic acid sample and system thereof | |
JP2014507141A5 (ru) | ||
RU2597981C2 (ru) | Способ и система для определения нуклеотидной последовательности в заданной области генома плода | |
JP2018524993A5 (ru) |